ISHLT/Enduring Hearts Pediatric Heart Transplantation Innovation Challenge Grant Finalist Presentations

Tuesday, 29 November  |  2:00 – 3:15 p.m. EST


 
Five selected finalists present their research proposals to expert judges to determine the 2022 recipient of the ISHLT/Enduring Hearts Pediatric Heart Transplantation Innovation Challenge Grant Recipient.

Presented jointly by ISHLT and Enduring Hearts, the purpose of this grant is to support research that focuses on improving outcomes for pediatric patients who undergo heart transplantation. Proposals should focus on:
 
  1. Reducing/eliminating rejection and/or cardiac allograft vasculopathy (CAV) through innovative management of children/adolescents waiting for, and immediately after receiving, a heart transplant.
  2. Innovations and/or new technologies for early detection and/or treatment of rejection and/or CAV applicable to children and adolescents.
     
Moderator:
Kathy Grady, PhD, RN, MS, FAAN
, ISHLT Grants and Awards Committee Chair

Grant Finalists:
Carmel Bogle, MD
, Johns Hopkins Children's Center, Baltimore, MD USA
The Impact of Adverse Childhood Events on Cardiometabolic Risk in Pediatric Heart Transplant Recipients

Lakshmi Gokanapudy Hahn, MD, Washington University in St. Louis, St. Louis, MO USA
Clonal Hematopoiesis in Heart Transplant Recipients

Peter MacDonald, MD, PhD, FRACP, St. Vincent's Hospital, Sydney, Australia
Presented by: Andrew Jabbour, MBBS, PhD, FRACP
Establishing the Feasibility of Native CMR Imaging for the Diagnosis of Cardiac Allograft Rejection in Pediatric Orthotopic Heart Transplant Recipients

Emil Najjar, MD, PhD, Karolinska Institutet, Stockholm, Sweden
Presented by: Rikard Grankvist, MD
Heart Biopsy by Micro-Catheter Technique and Molecular Biology Analysis for Diagnosis of Heart Transplant Rejection

Madeleine Orban, MD, University Hospital of Munich, Ludwig-Maximilians Universit, Munich, Germany
Analysis of Associations of Age-Dependent Patterns of Cardiac Allograft Vasculopathy in Pediatric Heart Transplanted Patients with Modifiable Risk Factors